This inventor holds 11 USPTO granted patents and 1 EPO patent. Top assignees: Kowa Company Limited, Asahi Kasei Kogyo Kabushiki Kaisha, Chemo-Sero-Therapeutic Research Institute. Active years: 1985-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sayama, JP (1989 - 2006)
- Saitama, JP (1985 - 2007)
Company Filing History:
11 out of 605 
2 out of 1,297 
1 out of 151 Years Active: 1985-2007
Title: Hideo Yoshizaki: Innovator in Water-soluble Pharmaceuticals
Introduction
Hideo Yoshizaki, a distinguished inventor located in Sayama, Japan, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 11 patents. His innovative work focuses primarily on water-soluble compounds, which play a critical role in enhancing drug efficacy and absorption.
Latest Patents
Yoshizaki's recent inventions include a patent for a water-soluble phenylpyridazine derivative and a medicinal formulation containing it. This phenylpyridazine derivative is characterized by its ability to inhibit interleukin-1β production, showing promising results in medicinal applications. It possesses excellent water solubility and high oral absorbability, making it a critical advancement in the pharmaceutical industry. Another notable patent features water-soluble phenylpyridazine compounds that also exhibit similar properties and effectiveness in medicinal formulations.
Career Highlights
Throughout his career, Hideo Yoshizaki has been associated with reputable companies including Kowa Company Limited and Asahi Kasei Kogyo Kabushiki Kaisha. His work has not only increased the scope of pharmaceutical applications but also contributed significantly to enhancing therapeutic options for patients requiring effective treatments.
Collaborations
Yoshizaki has collaborated with esteemed colleagues in the industry, such as Yoshinori Kyotani and Hiromichi Shigyo. These partnerships highlight the importance of teamwork in driving innovation within the highly competitive field of pharmaceutical research and development.
Conclusion
Hideo Yoshizaki remains a prominent figure in the realm of pharmaceutical innovations. His dedication to developing water-soluble compounds has the potential to transform medicine and improve the quality of treatment for numerous conditions. As the industry advances, Yoshizaki's inventions will likely continue to influence the future of drug formulations, benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile